Go Pro

Agilon Health (AGL) Competitors

Agilon Health logo
$89.60 -3.01 (-3.25%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$89.61 +0.02 (+0.02%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AGL vs. RDNT, LFST, BLLN, OPCH, and CRVL

Should you buy Agilon Health stock or one of its competitors? Agilon Health's main competitors and comparable companies include RadNet (RDNT), LifeStance Health Group (LFST), Billiontoone (BLLN), Option Care Health (OPCH), and CorVel (CRVL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Agilon Health compare to RadNet?

RadNet (NASDAQ:RDNT) and Agilon Health (NYSE:AGL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

RadNet has a net margin of -0.93% compared to Agilon Health's net margin of -3.92%. RadNet's return on equity of 2.61% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.93% 2.61% 0.91%
Agilon Health -3.92%-119.38%-16.85%

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 19.22%. Agilon Health has a consensus price target of $97.70, suggesting a potential upside of 9.05%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts plainly believe RadNet is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.89
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21

RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.02, indicating that its share price is 202% more volatile than the broader market.

In the previous week, RadNet had 3 more articles in the media than Agilon Health. MarketBeat recorded 8 mentions for RadNet and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.61 beat RadNet's score of 0.55 indicating that Agilon Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 2.5% of Agilon Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

RadNet has higher earnings, but lower revenue than Agilon Health. RadNet is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.91-$18.65M-$0.27N/A
Agilon Health$5.93B0.25-$391.35M-$14.27N/A

Summary

RadNet beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does Agilon Health compare to LifeStance Health Group?

Agilon Health (NYSE:AGL) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.

85.5% of LifeStance Health Group shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, LifeStance Health Group had 12 more articles in the media than Agilon Health. MarketBeat recorded 17 mentions for LifeStance Health Group and 5 mentions for Agilon Health. LifeStance Health Group's average media sentiment score of 0.89 beat Agilon Health's score of 0.61 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
7 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilon Health has a beta of 3.02, suggesting that its share price is 202% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

Agilon Health currently has a consensus target price of $97.70, indicating a potential upside of 9.05%. LifeStance Health Group has a consensus target price of $12.88, indicating a potential downside of 0.73%. Given Agilon Health's higher probable upside, equities analysts plainly believe Agilon Health is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

LifeStance Health Group has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.25-$391.35M-$14.27N/A
LifeStance Health Group$1.42B3.48$9.66M$0.1399.77

LifeStance Health Group has a net margin of 3.19% compared to Agilon Health's net margin of -3.92%. LifeStance Health Group's return on equity of 3.39% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
LifeStance Health Group 3.19%3.39%2.33%

Summary

LifeStance Health Group beats Agilon Health on 14 of the 17 factors compared between the two stocks.

How does Agilon Health compare to Billiontoone?

Agilon Health (NYSE:AGL) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Agilon Health currently has a consensus price target of $97.70, suggesting a potential upside of 9.05%. Billiontoone has a consensus price target of $125.88, suggesting a potential upside of 27.44%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Billiontoone
2 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.45

Billiontoone has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.25-$391.35M-$14.27N/A
Billiontoone$305.11M15.28$7.45M$0.70141.10

Billiontoone has a net margin of 8.04% compared to Agilon Health's net margin of -3.92%. Billiontoone's return on equity of 9.96% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
Billiontoone 8.04%9.96%5.35%

In the previous week, Billiontoone had 6 more articles in the media than Agilon Health. MarketBeat recorded 11 mentions for Billiontoone and 5 mentions for Agilon Health. Agilon Health's average media sentiment score of 0.61 beat Billiontoone's score of 0.55 indicating that Agilon Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Billiontoone beats Agilon Health on 11 of the 13 factors compared between the two stocks.

How does Agilon Health compare to Option Care Health?

Agilon Health (NYSE:AGL) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Option Care Health has a net margin of 3.68% compared to Agilon Health's net margin of -3.92%. Option Care Health's return on equity of 18.74% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
Option Care Health 3.68%18.74%7.25%

98.1% of Option Care Health shares are owned by institutional investors. 2.5% of Agilon Health shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Agilon Health has a beta of 3.02, meaning that its stock price is 202% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

Agilon Health presently has a consensus price target of $97.70, indicating a potential upside of 9.05%. Option Care Health has a consensus price target of $29.92, indicating a potential upside of 27.44%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than Agilon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Option Care Health
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Option Care Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.25-$391.35M-$14.27N/A
Option Care Health$5.65B0.62$207.59M$1.3317.65

In the previous week, Agilon Health had 1 more articles in the media than Option Care Health. MarketBeat recorded 5 mentions for Agilon Health and 4 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.71 beat Agilon Health's score of 0.61 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Option Care Health beats Agilon Health on 12 of the 16 factors compared between the two stocks.

How does Agilon Health compare to CorVel?

Agilon Health (NYSE:AGL) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

51.4% of CorVel shares are held by institutional investors. 2.5% of Agilon Health shares are held by insiders. Comparatively, 39.7% of CorVel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Agilon Health had 3 more articles in the media than CorVel. MarketBeat recorded 5 mentions for Agilon Health and 2 mentions for CorVel. CorVel's average media sentiment score of 1.73 beat Agilon Health's score of 0.61 indicating that CorVel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilon Health
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CorVel
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Agilon Health presently has a consensus target price of $97.70, suggesting a potential upside of 9.05%. Given Agilon Health's stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilon Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

CorVel has a net margin of 11.72% compared to Agilon Health's net margin of -3.92%. CorVel's return on equity of 29.92% beat Agilon Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilon Health-3.92% -119.38% -16.85%
CorVel 11.72%29.92%17.82%

CorVel has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilon Health$5.93B0.25-$391.35M-$14.27N/A
CorVel$958.53M3.69$110.34M$2.2530.79

Agilon Health has a beta of 3.02, meaning that its stock price is 202% more volatile than the broader market. Comparatively, CorVel has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

Summary

CorVel beats Agilon Health on 10 of the 16 factors compared between the two stocks.

Get Agilon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGL vs. The Competition

MetricAgilon HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.51B$9.84B$7.17B$23.39B
Dividend YieldN/A2.61%2.57%3.56%
P/E Ratio-6.2833.53274.9428.71
Price / Sales0.254.89685.4521.10
Price / CashN/A125.1576.6534.17
Price / Book11.735.2910.334.74
Net Income-$391.35M$313.25M$3.50B$1.07B
7 Day Performance1.72%-1.26%-3.32%-2.00%
1 Month Performance2.69%-0.98%-0.41%-2.69%
1 Year Performance236.51%15.13%19.21%10.45%

Agilon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
Agilon Health
1.3371 of 5 stars
$89.60
-3.2%
$97.70
+9.0%
+231.8%$1.51B$5.93BN/A856
RDNT
RadNet
3.1668 of 5 stars
$73.71
flat
$90.00
+22.1%
+2.4%$5.80B$2.04BN/A11,264
LFST
LifeStance Health Group
2.7216 of 5 stars
$12.73
flat
$12.38
-2.8%
+142.9%$4.94B$1.42B97.9310,961
BLLN
Billiontoone
3.9192 of 5 stars
$99.39
flat
$125.88
+26.6%
N/A$4.69B$305.11M141.99620
OPCH
Option Care Health
3.8244 of 5 stars
$24.21
flat
$29.92
+23.6%
-20.1%$3.63B$5.65B18.208,266

Related Companies and Tools


This page (NYSE:AGL) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners